Financing of German biotechs

The German biotech indus­try plans to hire more staff and invest in 2017. The finan­cing situa­tion has also stabi­li­zed at a high level. This is shown by the results of a joint survey by BIO Deutsch­land and |tran­skript.
Two-thirds of the compa­nies surveyed assess the current busi­ness situa­tion as good, and 54% also expect a further impro­ve­ment in 2017. Accor­ding to the report, invest­ments in German biotech compa­nies in 2016 were again at a high level of 505 million euros, even though there was a decline of 8% compared to the record year 2015 (550 million euros).